Osteoarthritis Biomarker
Osteoarthritis Biomarker - Related Videos
09:26
The Monoiodoacetate Model of Osteoarthritis Pain in the Mouse
0 Views •
Cited by 181 •
2016
Osteoarthritis (OA), or degenerative joint disease, is a debilitating condition associated with pain that remains only partially controlled by available analgesics. Animal models are being developed to improve our understanding of OA-related pain mechanisms. Here we describe the methodology for the monoiodoacetate model of OA pain in the mouse.
08:29
Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD
0 Views •
Cited by 29 •
2012
We describe a rat model of post traumatic stress disorder (PTSD) that reveals the persistent alterations in neuroendocrine function and the delayed long-term, exaggerated fear response, characteristic of PTSD patients. The animal model and methods described here are useful for correlating biomarkers in brain nuclei, which are mechanistic but cannot be measured in patients, with biomarkers in peripheral white blood cells, which can.
07:58
Establishment of a Surgically-induced Model in Mice to Investigate the Protective Role of Progranulin in Osteoarthritis
0 Views •
Cited by 47 •
2014
We describe a protocol for the destabilization of the medial meniscus (DMM) model in mice, an effective tool for osteoarthritis (OA) research. In addition, we have demonstrated that deficiency of progranulincan exaggerate OA development and progression by using this model, indicating that progranulin plays a protective role in the pathogenesis of OA.
08:28
An Overview of bGDGT Biomarker Analysis for Paleoclimatology
0 Views •
2023
Source: Laboratory of Jeff Salacup - University of Massachusetts Amherst Throughout this series of videos, natural samples were extracted and purified in search of organic compounds, called biomarkers, that can relate information on climates and environments of the past. One of the samples analyzed was sediment. Sediments accumulate over geologic time in basins, depressions in the Earth into which sediment flows through the action of fluid (water or air), movement, and gravity. Two main types...
07:24
Sonication Extraction of Lipid Biomarkers from Sediment
0 Views •
2023
Source: Laboratory of Jeff Salacup - University of Massachusetts Amherst The material comprising the living "organic" share of any ecosystem (leaves, fungi, bark, tissue; Figure 1) differs fundamentally from the material of the non-living "inorganic" share (rocks and their constituent minerals, oxygen, water, metals). Organic material contains carbon linked to a series of other carbon and hydrogen molecules (Figure 2), which distinguishes it from inorganic material. Carbon's wide valency range...
FAQs
Matrix breakdown, altered cell signaling, and cytokine-driven responses provide distinct biological routes for osteoarthritis biomarkers to emerge. Cartilage damage can release measurable molecular signals, while synovial tissue activity reflects local inflammatory regulation. Considering these processes together helps researchers relate a biomarker pattern to both joint pathology and immune activity rather than treating a single measurement as a complete description of disease.
Cytokine-driven responses indicate that osteoarthritis can include localized, low-grade inflammatory activity alongside tissue degeneration. Biomarker changes associated with these responses may therefore provide information about immune signaling within the joint, not only structural damage. In immunology research, this distinction is useful when comparing osteoarthritis-related inflammation with other inflammatory conditions that may produce overlapping clinical or molecular findings.
A biomarker measurement represents molecular or cellular activity, whereas cartilage and synovial changes provide information about the affected joint tissues. Relating these observations can clarify whether a signal corresponds more closely to matrix breakdown, local inflammatory regulation, or broader disease progression. This integrated interpretation helps connect laboratory findings with structural damage and reported symptoms without relying on one type of evidence alone.
Blood, synovial fluid, and joint tissue offer different views of osteoarthritis-related biology. Blood measurements can support assessment outside the joint, synovial fluid can reflect the local joint environment, and tissue analysis can connect biomarker activity directly with cartilage or synovial changes. Comparing these sources helps researchers determine how closely a measured signal represents local pathology versus broader biological activity.
Researchers first identify a measurable molecule, cell, or imaging feature linked to the disease process, then assess it in blood, synovial fluid, or joint tissue. They compare the measurement with structural damage, symptoms, or disease progression to determine its relevance. This workflow allows molecular activity to be evaluated as a potential indicator for detection, patient stratification, or treatment assessment.
These biomarkers are useful when investigators need to distinguish osteoarthritis-associated, low-grade joint inflammation from other inflammatory or infectious conditions. Their value extends beyond detection: measurements can help identify biological differences among patients and evaluate whether treatment is associated with reduced inflammation or preservation of cartilage. This makes them relevant to disease characterization, stratification, and monitoring in joint research.